Yatharth Hospital & Trauma Care Services Limited (YATHARTH.BO)
- Previous Close
522.70 - Open
517.85 - Bid 519.10 x --
- Ask 522.85 x --
- Day's Range
504.25 - 524.70 - 52 Week Range
345.35 - 692.85 - Volume
17,205 - Avg. Volume
30,466 - Market Cap (intraday)
50.364B - Beta (5Y Monthly) --
- PE Ratio (TTM)
35.34 - EPS (TTM)
14.73 - Earnings Date May 27, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
598.00
Yatharth Hospital & Trauma Care Services Limited, together with its subsidiaries, owns and operates super-specialty hospitals in Delhi and Madhya Pradesh. The company offers services in the areas of medicine; cardiology; neurosciences; general surgery; nephrology and urology; pediatric; gastroenterology; pulmonology; gynecology; orthopedics and spine and rheumatology; plastic and cosmetic surgery; ear, nose, and throat; endocrinology; critical care; dermatology; nuclear medicine; cancer and bone marrow transplant; GI surgery and liver transplant; robotic surgery; IVF and fertility; ophthalmology; dentistry; psychology and psychiatry; physiotherapy and rehabilitation; anesthesiology; radiology; pathology and laboratory medicine; nutrition and health; and interventional spine and pain medicine. It also sells medicines and canteen food, etc. Yatharth Hospital & Trauma Care Services Limited was incorporated in 2008 and is based in Noida, India.
www.yatharthhospitals.comRecent News: YATHARTH.BO
View MorePerformance Overview: YATHARTH.BO
Trailing total returns as of 6/13/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: YATHARTH.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: YATHARTH.BO
View MoreValuation Measures
Market Cap
50.16B
Enterprise Value
45.13B
Trailing P/E
35.36
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.24
Price/Book (mrq)
3.12
Enterprise Value/Revenue
5.12
Enterprise Value/EBITDA
19.09
Financial Highlights
Profitability and Income Statement
Profit Margin
14.83%
Return on Assets (ttm)
7.41%
Return on Equity (ttm)
10.40%
Revenue (ttm)
8.8B
Net Income Avi to Common (ttm)
1.31B
Diluted EPS (ttm)
14.73
Balance Sheet and Cash Flow
Total Cash (mrq)
5.15B
Total Debt/Equity (mrq)
0.71%
Levered Free Cash Flow (ttm)
-1.55B